Trisomy 21 and Risk of Retinopathy of Prematurity.


BACKGROUND AND OBJECTIVES Trisomy 21 is known to decrease the risk of several (nonocular) angiogenic-mediated diseases. The objective of this study was to determine whether trisomy 21 can also be shown to be significantly protective against ocular angiogenic-mediated disorders such as retinopathy of prematurity (ROP). METHODS A retrospective analysis of… (More)
DOI: 10.1542/peds.2015-0623


3 Figures and Tables